Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 807.9K | -- | 2.79% | +787.8K | 2026-06-30 |
| Virtu Financial LLC | 124.3K | -- | 0.43% | +73.4K | 2026-06-30 |
| Morgan Stanley | 50.9K | -- | 0.18% | +50.0K | 2026-06-30 |
| Geode Capital Management, LLC | 46.0K | -- | 0.16% | +16.1K | 2026-06-30 |
| Goldman Sachs Group Inc | 32.4K | -- | 0.11% | -- | 2026-06-30 |
| UBS Group AG | 28.9K | -- | 0.10% | +27.8K | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 17.5K | -- | 0.06% | -- | 2026-06-30 |
| Ground Swell Capital, LLC | 12.2K | -- | 0.04% | -- | 2026-06-30 |
| Tower Research Capital LLC (TRC) | 4.7K | -- | 0.02% | -- | 2026-06-30 |
